For those interested in an academic treatment to the how Pioneers performed in their first year, see this special report just released from The New England Journal of Medicine. Researchers compared ACO financial performance versus controls for the first time (that we are aware of) at the beneficiary level and found a 1.2 percent lower spend for recipients in the ACO group.

Leave a comment